{"id":"https://openalex.org/keywords/fevipiprant","display_name":"fevipiprant","description":"Fevipiprant is an oral small-molecule antagonist of the prostaglandin D2 receptor CRTh2, studied as a treatment for allergic asthma and nasal polyposis.","display_name_alternatives":["QAW039","NVP-QAW039","QAW-039"],"ids":{"openalex":"https://openalex.org/keywords/fevipiprant","wikidata":"https://www.wikidata.org/wiki/Q27077292"},"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.622,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.622,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0717,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"works_count":101,"cited_by_count":1407,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/fevipiprant","updated_date":"2026-11-20T04:06:44","created_date":"2022-04-12T19:38:12"}
